登入
選單
返回
Google圖書搜尋
Regulation, Generic Competition and Pharmaceutical Prices
Kurt Richard Brekke
Tor Helge Holmas
Odd Rune Straume
其他書名
Theory and Evidence from a Natural Experiment
出版
SSRN
, 2014
URL
http://books.google.com.hk/books?id=vzLizwEACAAJ&hl=&source=gbs_api
註釋
We study the impact of regulatory regimes on generic competition and pharmaceutical pricing using a unique policy experiment in Norway, where reference pricing (RP) replaced price cap regulation in 2003 for a sub-sample of off-patent products. We exploit a detailed panel dataset at product level covering a wide set of off-patent drugs before and after the policy reform. Off-patent drugs not subject to reference pricing serve as our control group. We find that RP leads to lower relative prices, with the effect being driven by strong brand-name price reductions, and not increases in generic prices. We also find that RP increases generic competition, resulting in lower brand-name market shares. Finally, we show that RP has a strong negative effect on average prices at molecule level, suggesting significant cost-savings.
